LIVANTEX - Company finances
|
EUR
|
2018
From: 2018-01-01
To: 2018-12-31
|
2019
From: 2019-01-01
To: 2019-12-31
|
2020
From: 2020-01-01
To: 2020-12-31
|
2021
From: 2021-01-01
To: 2021-12-31
|
2022
From: 2022-01-01
To: 2022-12-31
|
2023
From: 2023-01-01
To: 2023-12-31
|
2024
From: 2024-01-01
To: 2024-12-31
|
2025
From: 2025-01-01
To: 2025-12-31
|
|---|---|---|---|---|---|---|---|---|
|
Financial data
|
||||||||
| Sales revenue | 19,318 | 18,772 | 18,782 | 28,847 | 25,319 | 25,196 | 46,522 | 38,476 |
| Profit before tax | - | - | - | - | - | - | - | - |
| Net profit | 185 | -2,448 | -2,405 | 4,693 | -1,774 | -2,091 | 5,563 | -106 |
| Equity | 5,819 | 3,371 | 966 | 5,659 | 3,885 | 1,794 | 7,358 | 7,252 |
| Liabilities | 12,416 | 15,038 | 23,631 | 21,321 | 20,410 | 17,590 | 16,339 | 15,898 |
| Non-current assets | 0 | 1,013 | 574 | 135 | 0 | 0 | 0 | 0 |
| Current assets | 18,235 | 17,396 | 24,023 | 26,845 | 24,295 | 19,384 | 23,697 | 23,150 |
| Total assets | 18,235 | 18,409 | 24,597 | 26,980 | 24,295 | 19,384 | 23,697 | 23,150 |
|
Taxes paid
|
||||||||
| STI taxes | - | - | - | - | - | 5,927 | 9,175 | 8,490 |
|
Financial indicators
|
||||||||
| Revenue change y/y | +13.6% | -2.8% | +0.1% | +53.6% | -12.2% | -0.5% | +84.6% | -17.3% |
| ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. | 1.0% | -13.3% | -9.8% | 17.4% | -7.3% | -10.8% | 23.5% | -0.5% |
| ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. | 3.2% | -72.6% | -249.0% | 82.9% | -45.7% | -116.6% | 75.6% | -1.5% |
| Profit margin Net profit margin. Shows the overall profitability of the company. | 1.0% | -13.0% | -12.8% | 16.3% | -7.0% | -8.3% | 12.0% | -0.3% |
| EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. | - | - | - | - | - | - | - | - |
| Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. | 2.1 | 4.5 | 24.5 | 3.8 | 5.3 | 9.8 | 2.2 | 2.2 |
| Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. | 15,454 | 18,772 | 18,782 | 28,847 | 25,319 | 25,196 | 46,522 | 38,476 |
Sales revenue
See Scoris data in Google Search
Mark Scoris as a favorite source. One click, no registration.
LIVANTEX - Social security debts
| From | To | Debt, € |
|---|---|---|
| 2026-05-03 | 2026-05-13 | 0.06 |
| 2026-04-20 | 2026-04-29 | 0.06 |
| 2026-03-29 | 2026-04-12 | 0.06 |
| 2026-03-17 | 2026-03-27 | 0.06 |
| 2026-02-18 | 2026-03-05 | 0.06 |
| 2026-01-16 | 2026-02-16 | 0.06 |
| 2026-01-01 | 2026-01-07 | 0.06 |
| 2025-12-16 | 2025-12-30 | 0.06 |
| 2025-11-18 | 2025-12-14 | 0.06 |
| 2025-10-16 | 2025-11-13 | 0.06 |
| 2025-09-16 | 2025-10-08 | 0.06 |
| 2025-09-07 | 2025-09-14 | 0.06 |
| 2025-08-31 | 2025-09-03 | 0.06 |
| 2025-08-19 | 2025-08-29 | 0.06 |
| 2025-07-24 | 2025-08-13 | 0.06 |
| 2025-01-02 | 2025-01-13 | 0.86 |
| 2024-12-22 | 2024-12-31 | 0.86 |
| 2024-12-17 | 2024-12-20 | 0.86 |
| 2024-11-18 | 2024-12-15 | 0.86 |
| 2024-10-24 | 2024-11-14 | 0.86 |
| 2024-07-16 | 2024-07-29 | 197.56 |
| 2024-06-18 | 2024-07-15 | 0.81 |
| 2024-05-16 | 2024-06-13 | 0.81 |
| 2024-04-16 | 2024-05-12 | 0.81 |
| 2024-03-18 | 2024-04-14 | 0.81 |
| 2024-02-19 | 2024-03-12 | 0.81 |
| 2024-01-23 | 2024-02-13 | 0.81 |
| 2023-11-16 | 2023-11-29 | 179.35 |
| 2023-10-25 | 2023-11-15 | 0.68 |
| 2023-10-17 | 2023-10-24 | 0.65 |
| 2023-09-18 | 2023-10-15 | 0.65 |
| 2023-08-17 | 2023-09-13 | 0.65 |
| 2023-07-18 | 2023-08-13 | 0.65 |
| 2023-06-16 | 2023-07-13 | 0.65 |
| 2023-05-16 | 2023-06-13 | 0.65 |
| 2023-05-02 | 2023-05-14 | 0.65 |
| 2023-04-18 | 2023-04-28 | 0.65 |
| 2023-03-16 | 2023-04-16 | 0.65 |
| 2023-02-17 | 2023-03-12 | 0.65 |
| 2023-02-06 | 2023-02-13 | 0.65 |
| 2023-01-17 | 2023-02-03 | 0.65 |
| 2022-12-16 | 2022-12-29 | 0.65 |
| 2022-11-21 | 2022-12-13 | 0.65 |
| 2022-11-17 | 2022-11-18 | 0.65 |
| 2022-10-28 | 2022-11-10 | 0.65 |
| 2022-09-16 | 2022-09-28 | 156.20 |
| 2022-08-23 | 2022-09-15 | 0.93 |
| 2022-07-18 | 2022-08-15 | 0.93 |
| 2022-06-16 | 2022-07-13 | 0.93 |
| 2022-05-17 | 2022-06-13 | 0.93 |
| 2022-04-28 | 2022-05-15 | 0.93 |
| 2022-02-17 | 2022-03-06 | 155.84 |
| 2022-01-31 | 2022-02-16 | 0.57 |
| 2021-11-16 | 2021-11-25 | 136.96 |
| 2021-11-05 | 2021-11-15 | 0.41 |
LIVANTEX - VMI tax arrears
| From | To | Overdue, € |
|---|---|---|
| 2025-04-02 | 2025-04-23 | 1.56 |
VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.
Analysis of the company's financial position
This description was generated by artificial intelligence.
Report if inaccurate.
LIVANTEX, UAB (company code 302471064) is a private limited liability company engaged in the wholesale of pharmaceutical and medical goods. In 2025, the company generated revenue of EUR 38.5K, down 17.3% year on year after EUR 46.5K in 2024, but still above EUR 25.2K in 2023, showing a two-year increase of 52.7%. Net profit in 2025 was close to break-even at negative EUR 106, compared with a profit of EUR 5.6K in 2024 and a loss of EUR 2.1K in 2023. The profit margin therefore weakened to -0.3% in 2025 after 12.0% in 2024. At the end of 2025, total assets were EUR 23.1K, equity EUR 7.3K, and liabilities EUR 15.9K. The equity ratio stood at 31.3%, while debt-to-equity was 2.19. Return on equity was -1.5% and return on assets -0.5%, indicating a subdued earnings position. Asset turnover was 1.66x, and revenue per employee was EUR 38.5K in 2025.